2016. Prophylactic Intravenous Ketorolac for Prevention of Intraventricular Hemorrhage in Preterm Infants < 32 Weeks and < 1500 Grams: A Double-Blind, Randomized, Placebo-Controlled Trial. Acta Medica Philippina. 50, 2 (Jun. 2016). DOI:https://doi.org/10.47895/amp.v50i2.847.